Skip to main content
. 2024 Sep 1;9(3):201–206. doi: 10.22540/JFSF-09-201

Table 2.

Univariate and multivariate analysis with Cox proportional hazards model for overall survival in 1018 patients undergoing major urologic cancer surgery.

Variables Univariate Multivariate
HR (95% CI) P value HR (95% CI) P value
Age; ≥75 vs <75 years (ref) 2.66 (1.28-5.52) 0.009
Sex; female vs male (ref) 4.14 (1.89-9.07) <0.001
SARC-F questionnaire;
 Strength: ≥1 vs <1 (ref) 3.07 (1.25-7.51) 0.014
 Assistance with walking: ≥1 vs <1 (ref) 5.01 (2.43-10.31) <0.001 2.18 (1.02-4.64) 0.044
  Rise from a chair: ≥1 vs <1 (ref) 2.79 (0.66-11.71) 0.161
  Climb stairs: ≥1 vs <1 (ref) 4.42 (2.07-9.44) <0.001
  Falls : ≥1 vs <1 (ref) 1.81 (0.63-5.19) 0.270
Body mass index; low vs high (ref) 1.04 (0.51-2.12) 0.923
ECOG-PS; ≥2 vs <2 (ref) 8.91 (2.70-29.39) <0.001
Charlson comorbidity index; ≥5 vs <5 (ref) 2.74 (0.37-20.13) 0.322
Cancer stage; ≥III vs <III (ref) 9.60 (4.27-21.57) <0.001 7.98 (3.52-18.10) <0.001
Surgical form;
 Radical cystectomy vs others (ref) 14.59 (6.79-31.36) <0.001
 Radical prostatectomy vs others (ref) 0.02 (0.03-0.15) <0.001 0.03 (0.01-0.22) <0.001
 Radical nephrectomy vs others (ref) 2.90 (1.01-8.31) 0.048
  Partial nephrectomy vs others (ref) 0.22 (0.03-1.63) 0.139
 Radical nephroureterectomy vs others (ref) 1.96 (0.68-5.62) 0.213
Surgical approaches; open vs others (ref) 3.42 (1.63-7.20) 0.001
Operative time, minutes; ≥169 vs <169 (ref) 5.88 (2.05-16.85) <0.001
Estimated blood loss, ml; ≥78 vs <78 (ref) 5.68 (1.98-16.30) 0.001 4.53 (1.52-13.50) 0.007
Blood transfusion; yes vs no (ref) 13.28 (6.21-28.41) <0.001 2.41 (1.06-5.53) 0.037

CI=Confidence interval. ECOG-PS=Eastern Cooperative Oncology Group-performance status. HR=Hazard ratio. SARC-F=Simple questionnaire to rapidly diagnose sarcopenia.